ATOMOXETINE
Tracking # 20-1063188
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
ATOMOXETINE IS INDICATED FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS AND CHILDREN OVER SIX YEARS. ALTHOUGH ATOMOXETINE IS ONLY FDA-APPROVED FOR TREATING ADHD, IT IS SOMETIMES USED OFF-LABEL TO TREAT ADULT PATIENTS WITH TREATMENT-RESISTANT DEPRESSION. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, AND MONITORING OF ATOMOXETINE.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.5h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.5h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.5h
AMA Category I
Physician Assistant
1.5h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.5h
AMA Category I